A Strategy to Delay the Development of Cisplatin Resistance by Maintaining a Certain Amount of Cisplatin-Sensitive Cells

Cisplatin (ddp), which is commonly employed in the treatment of many advanced cancers, often results in initial therapeutic success; however, rapid progression of ddp-resistant cells remains the main reason for treatment failure. Facd with such a problem, we investigated the fitness differences betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Guihua, Tang, Qianyuan, Yan, Hongli, Xie, Lijuan, Wang, Yun, Zheng, Xi Emily, Zhuge, Yuzheng, Shen, Shanshan, Zhang, Bin, Zhang, Xiaoqi, Wang, Jun, Wang, Wei, Zou, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428423/
https://www.ncbi.nlm.nih.gov/pubmed/28348367
http://dx.doi.org/10.1038/s41598-017-00422-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428423/
https://www.ncbi.nlm.nih.gov/pubmed/28348367
http://dx.doi.org/10.1038/s41598-017-00422-2

Ejemplares similares